GAM Systematic’s AbbVie ABBV Stock Holding History

GAM Systematic’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.58M	Buy	17,842 +972	+6%	+$74K	0.23%	166
2017 Q2	$1.22M	Buy	16,870 +7,295	+76%	+$490K	0.18%	240
2017 Q1	$624K	Buy	9,575 +329	+4%	+$20.7K	0.12%	325
2016 Q4	$579K	Buy	9,246 +1,003	+12%	+$61.2K	0.14%	297
2016 Q3	$520K	Buy	+8,243	New	+$534K	0.11%	362
2016 Q2	–	Sell	-1,398	Closed	-$80K	–	621
2016 Q1	$80K	Buy	+1,398	New	+$77.9K	0.02%	545
2015 Q2	–	Sell	-41,059	Closed	-$2.4M	–	363
2015 Q1	$2.4M	Buy	41,059 +9,892	+32%	+$598K	0.33%	124
2014 Q4	$2.04M	Buy	+31,167	New	+$1.96M	0.41%	84

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

GAM Systematic's ABBV Position: Q3 2017 in Review

GAM Systematic increased its AbbVie (ABBV) stake by 5.8% in Q3 2017, buying an estimated $74K and bringing the position to 17,842 shares worth $1.58M. The position accounts for 0.23% of the portfolio, ranked #166.

GAM Systematic first reported a position in ABBV in Q4 2014 and has held it in 8 quarters since. The position peaked at $2.4M in Q1 2015. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

GAM Systematic held 17,842 shares of AbbVie worth $1.58M as of Q3 2017.
GAM Systematic bought 972 AbbVie shares in Q3 2017, an estimated $74K.
AbbVie made up 0.23% of GAM Systematic's portfolio in Q3 2017, its #166 holding.
GAM Systematic first reported a position in AbbVie in Q4 2014 and has held it in 8 quarters since.
GAM Systematic's AbbVie position peaked at $2.4M in Q1 2015.
1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.